Aurobindo Pharma posts 39.5% rise in cons. net profit at Rs635.8cr

Revenue from operations rose 28.1% yoy to Rs5,444.6cr during the quarter under review from Rs4,250cr in the corresponding quarter of the previous year.

from India Infoline News Service https://ift.tt/2MOJxyK